L. Scarpato , P.A. Ascierto , M. Scalvenzi , A. Villani , P. Bossi , A. Alberti , V. De Giorgi , L. Licitra , M.C. Fargnoli , P. Savoia , M. Guida , F. Spagnolo , F. De Galitiis , I. Stanganelli , K. Peris
{"title":"意大利对多国批准后安全性研究(NISSO)的中期分析,以评估sonidegib在局部晚期基底细胞癌患者中的长期安全性:重点关注不良事件发生的时间","authors":"L. Scarpato , P.A. Ascierto , M. Scalvenzi , A. Villani , P. Bossi , A. Alberti , V. De Giorgi , L. Licitra , M.C. Fargnoli , P. Savoia , M. Guida , F. Spagnolo , F. De Galitiis , I. Stanganelli , K. Peris","doi":"10.1016/j.ejcskn.2025.100335","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100396,"journal":{"name":"EJC Skin Cancer","volume":"3 ","pages":"Article 100335"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Italian interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: focus on time to onset of adverse events\",\"authors\":\"L. Scarpato , P.A. Ascierto , M. Scalvenzi , A. Villani , P. Bossi , A. Alberti , V. De Giorgi , L. Licitra , M.C. Fargnoli , P. Savoia , M. Guida , F. Spagnolo , F. De Galitiis , I. Stanganelli , K. Peris\",\"doi\":\"10.1016/j.ejcskn.2025.100335\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100396,\"journal\":{\"name\":\"EJC Skin Cancer\",\"volume\":\"3 \",\"pages\":\"Article 100335\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJC Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772611825000564\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJC Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772611825000564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Italian interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: focus on time to onset of adverse events